Document is current
Any future updates will be listed below
-
Authors
Tas, Kerem Tuna
Lishewski, Phillip
Sheikhzadeh, Fatima Frosan
Smalec, Edgar
Recknagel, Niklas
Wündisch, Thomas
Holland, Angelique
Kirschbaum, Andreas
Elsayad, Khalid
Engenhart-Cabillic, Rita
Zink, Klemens
Vorwerk, Hilke
Adeberg, Sebastian
Gawish, Ahmed
-
Funding
Funding for this research was provided by:
Philipps-Universität Marburg
- License Information
-
More Information
Article History
Received: 16 May 2025
Accepted: 15 August 2025
First Online: 4 September 2025
Declarations
:
: S. Adeberg and Honoraria/travel reimbursementAccuray Inc., AstraZeneca GmbH, Servier, Bristol Myers Squibb GmbH & Co., MSD, Novocure GmbH, Merck KGaA, Fakultät Heidelberg, Fakultät Marburg, Sanofi Genzyme, SA: Research cooperations Novocure GmbH. SA: Scientific AdvisoryAccuray Inc., Sanofi Genzyme, Servier, Novartis, Novocure GmbH, Merck KGaA. K.T. Tas, P. Lishewski, F.F. Sheikhzadeh, E. Smalec, N. Recknagel, T. Wündisch, A. Holland, A. Kirschbaum, K. Elsayad, R. Engenhart-Cabillic, K. Zink, H. Vorwerk and A. Gawish declare that they have no competing interests.
: S. Adeberg and Honoraria/travel reimbursementAccuray Inc., AstraZeneca GmbH, Servier, Bristol Myers Squibb GmbH & Co., MSD, Novocure GmbH, Merck KGaA, Fakultät Heidelberg, Fakultät Marburg, Sanofi Genzyme, SA: Research cooperations Novocure GmbH. SA: Scientific AdvisoryAccuray Inc., Sanofi Genzyme, Servier, Novartis, Novocure GmbH, Merck KGaA. Informed consent was obtained from all individual participants included in the study.
